iShares Nasdaq Biotechnology ETF Stock Forecast, Price & News

iShares Nasdaq Biotechnology ETF's stock was trading at $106.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IBB shares have increased by 24.8% and is now trading at $133.47.
View which stocks have been most impacted by COVID-19.

iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Wednesday, March 25th. Stockholders of record on Thursday, March 26th will be paid a dividend of $0.0554 per share on Tuesday, March 31st. This represents a $0.22 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date of this dividend is Wednesday, March 25th.
View iShares Nasdaq Biotechnology ETF's dividend history.

iShares Nasdaq Biotechnology ETF shares split on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.

iShares Nasdaq Biotechnology ETF saw a decline in short interest in September. As of September 15th, there was short interest totaling 20,780,000 shares, a decline of 9.3% from the August 31st total of 22,920,000 shares. Based on an average trading volume of 3,112,100 shares, the short-interest ratio is presently 6.7 days.
View iShares Nasdaq Biotechnology ETF's Short Interest.

Some companies that are related to iShares Nasdaq Biotechnology ETF include iShares MSCI Emerging Markets ETF (EEM), SPDR Dow Jones Industrial Average ETF Trust (DIA), SPDR Bloomberg Barclays High Yield Bond ETF (JNK), DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), iShares MSCI Pacific ex Japan ETF (EPP), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), WisdomTree Emerging Markets High Dividend Fund (DEM), Tri-Continental (TY), Direxion Daily Financial Bull 3X Shares (FAS), Gabelli Equity Trust (GAB), Hercules Capital (HTGC), Liberty All-Star Equity Fund (USA) and Royce Value Trust (RVT).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Alibaba Group (BABA), Netflix (NFLX), Tesla (TSLA), Cisco Systems (CSCO), Bank of America (BAC), Johnson & Johnson (JNJ), Micron Technology (MU) and Paypal (PYPL).

iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Nasdaq Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include CHURCHILL MANAGEMENT Corp (2.24%), PNC Financial Services Group Inc. (0.94%), Envestnet Asset Management Inc. (0.60%), QVT Financial LP (0.44%), Total Investment Management Inc. (0.42%) and First Republic Investment Management Inc. (0.38%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Estate Counselors LLC, Sawtooth Solutions LLC, AE Wealth Management LLC, Janney Capital Management LLC, Glenmede Trust Co. NA, Bank of Nova Scotia, and Simplex Trading LLC.

IBB stock was purchased by a variety of institutional investors in the last quarter, including CHURCHILL MANAGEMENT Corp, Envestnet Asset Management Inc., Total Investment Management Inc., Stadion Money Management LLC, Advisors Preferred LLC, DAVENPORT & Co LLC, SG Americas Securities LLC, and QVT Financial LP.

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of IBB stock can currently be purchased for approximately $133.47.

iShares Nasdaq Biotechnology ETF has a market capitalization of $9.15 billion.